These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18330032)

  • 1. Recent highlights in clinical AIDS research.
    Laurence J
    AIDS Read; 2008 Feb; 18(2):64-6. PubMed ID: 18330032
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance and other factors involved in therapy failure.
    Mallol S
    Antivir Ther; 2001; 6 Suppl 2():21-7. PubMed ID: 11678475
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent FDA approvals and changes.
    AIDS Patient Care STDS; 2011 Feb; 25(2):124-5. PubMed ID: 21370547
    [No Abstract]   [Full Text] [Related]  

  • 4. Current clinical treatments of AIDS.
    Murphy EM; Jimenez HR; Smith SM
    Adv Pharmacol; 2008; 56():27-73. PubMed ID: 18086408
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral treatment of HIV infection.
    Thomas MG; Ellis-Pegler RB
    N Z Med J; 1998 Sep; 111(1074):353-4. PubMed ID: 11039818
    [No Abstract]   [Full Text] [Related]  

  • 6. Revisiting the concept of a genetic barrier to resistance.
    Rusconi S
    J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
    Sattler FR
    Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa.
    Barth RE; Wensing AM; Tempelman HA; Moraba R; Schuurman R; Hoepelman AI
    AIDS; 2008 Oct; 22(16):2210-2. PubMed ID: 18832885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
    Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
    Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-associated lipodystrophy syndrome.
    Mauss S
    AIDS; 2000; 14 Suppl 3():S197-207. PubMed ID: 11086863
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical management of HIV-associated lipodystrophy.
    Pirmohamed M
    Curr Opin Lipidol; 2009 Aug; 20(4):309-14. PubMed ID: 19494771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
    Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
    Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
    Cuzin L; Allavena C; Morlat P; Dellamonica P
    AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting report of the 10th European AIDS Conference (EACS) 17-20 November 2005.
    Chew N; Lambert JS
    J HIV Ther; 2005 Dec; 10(4):79-80. PubMed ID: 16519248
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
    Paraschiv S; Otelea D; Baicus C; Tinischi M; Costache M; Neaga E
    Int J Infect Dis; 2009 Jan; 13(1):81-9. PubMed ID: 18632295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding transmitted HIV resistance through the experience in the USA.
    Taiwo B
    Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good results for lipodystrophy drug.
    AIDS Patient Care STDS; 2007 Feb; 21(2):146. PubMed ID: 17328664
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
    Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
    Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.